FOCL

FOCALTHERICS

• Dow Jones·08/25 12:04

  EDAP TMS Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

• Benzinga·08/25 11:54

  HC Wainwright & Co. Reiterates Buy on Edap TMS, Maintains $10 Price Target

• TipRanks·08/25 10:26

  Analyst Reiterates Buy on FocalTherics, Maintains $10 Price Target Amid Strong U.S. Momentum and Growing Focal One Adoption

• TipRanks·08/23 00:07

  Edap TMS Earnings Call Highlights HIFU-Driven Surge

• TipRanks·08/19 10:48

  FocalTherics Completes ADS Offering, Boosting Capital Strength

• TipRanks·08/18 02:03

  FocalTherics Leadership Makes Bold Insider Move, Sparking Investor Buzz

• TipRanks·08/17 11:12

  FocalTherics announces American depositary shares offering

• TipRanks·08/16 14:07

  FocalTherics backs FY26 revenue view $50M-$54M, consensus $62.61M

• TipRanks·08/16 12:59

  Midday Fly By: Applied Materials reports Q3 beat, Trump slaps tariffs on drones

• TipRanks·08/14 10:33

  EDAP TMS Announces Underwritten ADS Public Offering

• Benzinga·08/13 21:29

  Edap TMS Q2 2026 Earnings Call: Complete Transcript

• Seeking Alpha·08/13 16:47

  Here are the major earnings after the close Thursday

• TipRanks·08/13 14:30

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: AgomAb Therapeutics NV ADR (AGMB), EDAP TMS (FOCL) and Sutro Biopharma (STRO)

• Benzinga·08/12 12:06

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• NASDAQ·08/12 10:09

  FocalTherics Reports Preliminary Q2 2026 Results, Announces $40 Million Offering; Stock Down